Skip to Content

We invite you to try out our new beta eCFR site at https://ecfr.federalregister.gov. We’ve made big changes to make the eCFR easier to use. Be sure to leave feedback using the 'Feedback' button on the bottom right of each page!

Notice

Notice of Designation of Scarce Materials or Threatened Materials Subject to COVID-19 Hoarding Prevention Measures; Change in Information Contact, Removal of Chloroquine Phosphate and Hydroxychloroquine HCl; Correction

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Office of the Secretary (OS), DHHS.

ACTION:

Notice; correction.

SUMMARY:

This document updates the March 30, 2020, Federal Register Notice entitled “Notice of Designation of Scarce Materials or Threatened Materials Subject to COVID-19 Hoarding Prevention Measures,” by replacing the named contact and updating the “Notice of Designation of Scarce Materials or Threatened Materials” section.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Paige Ezernack, Office of the Assistant Secretary for Preparedness and Response, Office of Strategy, Policy, Planning, and Requirements, Suite Start Printed Page 406685440—O'Neill House Office Building, 200 C Street SW, Washington, DC 20201, (202) 260-0365.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

I. Background

In FR Doc. 2020-06641 of March 30, 2020 (85 FR 17592-17593), the contact for more information is now aspr.dpa@hhs.gov. Chloroquine phosphate and hydroxychloroquine HCl are no longer listed as scarce or threatened materials following the withdrawal of the FDA emergency use authorizations for these drugs on June 15, 2020.

II. Correction of Errors

In FR Doc. 2020-06641 of March 30, 2020 (85 FR 17592-17593), make the following corrections:

On page 17592, first full column, in FR Doc. 2020-06641, Further Information section, change Bryan Shuy: 202-703-8610; bryan.shuy@hhs.gov (mail to: Bryan.Shuy@hhs.gov) to the ASPR DPA Office: 202-838-3420; aspr.dpa@hhs.gov.

On page 17593, first column, in FR Doc. 2020-06641, Notice of Designation of Scarce Materials or Threatened Materials, remove “Drug product with active ingredient chloroquine phosphate or hydroxychloroquine HCl.”

Start Signature

Dated: June 30, 2020.

Wilma Robinson,

Deputy Executive Secretary, Department of Health and Human Services.

End Signature End Supplemental Information

[FR Doc. 2020-14525 Filed 7-6-20; 8:45 am]

BILLING CODE 4150-37-P